Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | PPARG | P37231 | 7/20 | 0.43 |
| ▸ | PPARD | Q03181 | 7/20 | 0.43 |
| ▸ | PPARA | Q07869 | 7/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL924245 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL993403 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL4584710 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL1061636 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL1127820 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL5665394 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL2119178 | 1.00 | CES2 (0.44) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL28421147 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3GPR84PPARG | |
| SCHEMBL28279462 | 0.98 | CES2 (0.42) | CES2LPAR1LPAR3GPR84PPARG | |
| Ammonia Solution, Strong SCHEMBL28638428 | 0.96 | CES2 (0.41) | CES2LPAR1LPAR3GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2187859-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | Arizona Chemical Company (US) | 2010-05-26 | — | — | EP | claimed |
| WO-2009039158-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | ARIZONA CHEMICAL COMPANY (US) | 2009-03-26 | — | — | WO | claimed |
| US-20090074685-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | ARIZONA CHEMICAL COMPANY, LLC | 2009-03-19 | — | — | US | claimed |
| US-20120093896-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | CIBA CORPORATION (US) | 2012-04-19 | — | — | US | disclosed |
| CN-101801331-A | Polyamide and cosmetic composition, by the product of said composition preparation, and preparation and use the method for said composition and product | ARIZONA CHEM | 2010-08-11 | — | — | CN | disclosed |
| EP-2187859-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | Arizona Chemical Company (US) | 2010-05-26 | — | — | EP | disclosed |
| US-20100111884-A1 | UV ABSORBER FORMULATIONS | CIBA CORPORATION (US) | 2010-05-06 | — | — | US | disclosed |
| EP-2170250-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (DE) | 2010-04-07 | — | — | EP | disclosed |
| EP-2099530-A1 | UV ABSORBER FORMULATIONS | Ciba Holding Inc. (CH) | 2009-09-16 | — | — | EP | disclosed |
| US-20090196894-A1 | Self Tanning Composition | CIBA CORP. | 2009-08-06 | — | — | US | disclosed |
| WO-2009039158-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | ARIZONA CHEMICAL COMPANY (US) | 2009-03-26 | — | — | WO | disclosed |
| US-20090074685-A1 | POLYAMIDE AND EMOLLIENT COMPOSITIONS, PRODUCTS MADE THEREFROM, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS AND PRODUCTS | ARIZONA CHEMICAL COMPANY, LLC | 2009-03-19 | — | — | US | disclosed |
| EP-2026746-A2 | SELF TANNING COMPOSITION | Ciba Holding Inc. (CH) | 2009-02-25 | — | — | EP | disclosed |
| WO-2009016064-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (CH) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008080892-A1 | UV ABSORBER FORMULATIONS | CIBA HOLDING INC. (CH) | 2008-07-10 | — | — | WO | disclosed |
| WO-2007137958-A2 | SELF TANNING COMPOSITION | CIBA HOLDING INC. (CH) | 2007-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100111884-A1 | UV ABSORBER FORMULATIONS | C1R, C1S, C9 | CES2 889/4885LPAR1 3396/4885LPAR3 3145/4885 |
| US-20090196894-A1 | Self Tanning Composition | C9, KRT18, F12 | CES2 2834/4885LPAR1 2942/4885LPAR3 1458/4885 |
| US-20120093896-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | CUTA, PROC, RBP1 | CES2 1439/4885LPAR1 3555/4885LPAR3 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.